Clinical Trials · NCT03946527
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Antonio Fojo
- Enrollment
- 10
- Start date
- Jun 2019
- Locations
- 2 sites, United States
- Primary endpoint
- Rate of tumor growth